Profil
Misty Stevens is the founder and currently holds the position of Chief Operating Officer at InterveXion Therapeutics LLC, which was founded in 2004.
Dr. Stevens is also the founder and currently holds the position of Chief Operating Officer at Kuria Therapeutics, Inc., which was founded in 2022.
Aktive Positionen von Misty Stevens
| Unternehmen | Position | Beginn |
|---|---|---|
InterveXion Therapeutics LLC
 InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Gründer | 01.01.2004 |
Kuria Therapeutics, Inc.
 Kuria Therapeutics, Inc. BiotechnologyHealth Technology Kuria Therapeutics, Inc. is a company that focuses on the biology of NRF2, which is the body's master regulator of the cytoprotective, antioxidant, and detoxification response. The company is based in Little Rock, AZ. The company is developing a potent NRF2 activator for multiple ophthalmic and dermatologic conditions. The company was founded by Keith W. Ward, Misty Stevens. Keith W. Ward has been the CEO since incorporation. | Gründer | 01.02.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
InterveXion Therapeutics LLC
InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Health Technology |
Kuria Therapeutics, Inc.
Kuria Therapeutics, Inc. BiotechnologyHealth Technology Kuria Therapeutics, Inc. is a company that focuses on the biology of NRF2, which is the body's master regulator of the cytoprotective, antioxidant, and detoxification response. The company is based in Little Rock, AZ. The company is developing a potent NRF2 activator for multiple ophthalmic and dermatologic conditions. The company was founded by Keith W. Ward, Misty Stevens. Keith W. Ward has been the CEO since incorporation. | Health Technology |
